Back to MORGAN STANLEY MORGAN STANLEY

PCRXPCRX
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in PACIRA BIOSCIENCES INC

MORGAN STANLEY holds 1.1M shares of PCRX (PACIRA BIOSCIENCES INC), worth $29M as of 2026-Q2. The position was decreased (-17.8% shares). PCRX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$29M

Current Shares

1.1M

Total Value Change

+$5M

Total Shares Change

-451,235

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.1M
-17.8%
$29M0.0%$25.37
0
2026-Q1
Increased
1.4M
+16.8%
$31.5M0.0%$22.10
33
2025-Q4
Increased
1.2M
+4.4%
$30.9M0.0%$26.07
30
2025-Q3
Increased
1.1M
+20.3%
$29.4M0.0%$25.34
34
2025-Q2
Decreased
950,036
-4.8%
$22.7M0.0%$23.48
0
2025-Q1
Decreased
997,606
-9.7%
$24.8M0.0%$24.91
0
2024-Q4
Decreased
1.1M
-30.8%
$20.8M0.0%$18.94
0
2024-Q3
Increased
1.6M
+209.2%
$24M0.0%$14.54
46

Other major holders of PCRX: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used